Scopus
YÖKSİS DOI Eşleşti
SJR Q2
The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma
Cancer Biomarkers · Ocak 2017
Özet
BACKGROUND: Ring Box Protein-1 (RBX-1), a component of SCF E3 ubiquitin ligases, has a crucial role in bladder urothelial cell carcinoma (UCC) carcinogenesis and progression. OBJECTIVES: In the present study, it is aimed to determine the expression of RBX-1 protein in bladder UCC and the association between tumor grade, stage and RBX-1 expression. METHODS: Ninety UCC samples and 20 samples containing foci of normal bladder urothelium were recruited and analyzed immunohistochemically in terms of RBX-1 expression. Immuno-reactivity scoring system (IRS) was used to determine RBX-1 expression levels. RESULTS: RBX-1 overexpression was associated with high tumor grade (p= 0.001) and advanced stage (p= 0.001). pT1 tumors showed higher RBX-1 expression than pTa tumors. pT2 tumors showed not only higher expression than pTa tumors but also higher expression than the total of pTa and pT1 groups combined. There was no statistically significant relation between RBX-1 expression and patient gender (p= 0.116) or age (p= 0.191). CONCLUSIONS: In bladder UCC, RBX-1 overexpression is associated with high tumor grade and advanced stage and represents biological potential of invasiveness and aggressive disease. Results of the present study have to be supported with further studies to reveal clinical and therapeutic implications of RBX-1 overexpression in bladder UCC.
YÖKSİS Kayıtları
The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma
Cancer Biomarkers · 2017 SCI-Expanded
Prof. Dr. MEHMET KAYNAR →
The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma
Cancer Biomarkers · 2017 SCI-Expanded
Prof. Dr. ZELİHA ESİN ÇELİK →
The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma
Cancer Biomarkers · 2017 SCI-Expanded
Prof. Dr. SERDAR GÖKTAŞ →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 6 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 6 kaydı bulundu.
Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio
2015 ISSN: 15740153 SCI-Expanded
Prof. Dr. MEHMET KAYNAR →
Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio
2015 ISSN: 15740153 SCI-Expanded
Prof. Dr. ÖZCAN KILIÇ →
Association of Endocan Expression with Clinicopathological Prognostic Parameters In Breast Carcinoma
2021 ISSN: 1574-0153 SCI-Expanded Q2
Prof. Dr. ZELİHA ESİN ÇELİK →
Association of endocan expression with clinicopathological prognostic parameters in breast carcinoma
2021 ISSN: 1574-0153 SCI-Expanded Q2
Prof. Dr. NEVZAT SERDAR UĞRAŞ →
Association of endocan expression with clinicopathological prognostic parameters in breast carcinoma
2021 ISSN: 1574-0153 SCI-Expanded Q2
Dr. Öğr. Üyesi HARUN YONAR →
Association of endocan expression with clinicopathological prognostic parameters in breast carcinoma
2021 ISSN: 1574-0153 SCI-Expanded Q2
Öğr. Gör. FATİH DEMİR →
Makale Bilgileri
Dergi
Cancer Biomarkers
Toplam Atıf
4 atıf
· Scopus
ISSN15740153
Yayın TarihiOcak 2017
Cilt / Sayfa20 · 389-394
Scopus ID2-s2.0-85039167615
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 4.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Cancer Biomarkers
Q2
SJR Skoru0,572
H-Index60
YayıncıSAGE Publications Ltd
ÜlkeUnited Kingdom
Medicine (miscellaneous) (Q2)
Cancer Research (Q3)
Genetics (Q3)
Oncology (Q3)
Metrikler
4
Atıf